A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children



Status:Completed
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 65
Updated:3/16/2015
Start Date:February 2015
End Date:April 2015
Contact:This is a single site clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Phone:1-317-615-4559

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects

The purpose of this study is to evaluate how much of the LY2801653 drug is available in the
body when given in 2 different formulations with and without a meal to healthy participants
who are not able to have children. In addition, this study will measure how much of the drug
gets into the blood stream and how long it takes the body to get rid of it. Information
about any side effects that may occur will also be collected. The study will last about 27
days. Screening is required within 28 days prior to the start of the study.


Inclusion Criteria:

- Generally healthy sterile male and female participants

- Body mass index (BMI) of 18.0 to 32.0 kilograms per square meter (kg/m^2), inclusive

- Are willing and able to eat the protocol specified high-fat breakfast

Exclusion Criteria:

- Have consumed grapefruits or grapefruit-containing products, Seville oranges or
Seville orange juice, star fruit, star fruit juice, or star fruit-containing
products, or commercial apple or orange juice within 14 days prior to first dosing

- Regularly use known drugs of abuse and/or show positive findings on urinary drug
screening

- Have donated blood of more than 500 milliliter (mL) within the last month
We found this trial at
1
site
Covance, Inc.
Daytona Beach, Florida 32117
?
mi
from
Daytona Beach, FL
Click here to add this to my saved trials